Sign in
USA
UK
Germany
France
Canada
India
Italy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
FinSMEs
The Website About Venture Capital News
FinSMEs
The Website About Venture Capital News
USA
UK
Germany
France
Canada
India
Italy
Search
Home
Tags
Gilead Sciences
Tag: Gilead Sciences
USA
Gilead Sciences Completes Acquisition of CymaBay, for Approximately $4.3 Billion
FinSMEs
-
March 25, 2024
0
UK
Gilead Sciences to Buy MiroBio, for $405M
FinSMEs
-
August 5, 2022
0
USA
Exavir Therapeutics Closes $4M Seed Financing
FinSMEs
-
May 23, 2022
0
USA
Curebase Raises $40M in Series B Funding
FinSMEs
-
May 5, 2022
0
USA
Kyverna Therapeutics Raises $85M in Series B Financing
FinSMEs
-
January 26, 2022
0
USA
Lyndra Therapeutics Closes $60.5M Series C Financing
FinSMEs
-
June 27, 2021
0
UK
Vaccitech Raises $168M in Series B Financing
FinSMEs
-
March 18, 2021
0
Germany
Gilead Sciences to Buy MYR GmbH, for $1.15 Billion
FinSMEs
-
December 10, 2020
0
USA
Gilead Sciences Completes Acquisition of Immunomedics
FinSMEs
-
October 23, 2020
0
USA
Gilead Sciences to Buy Immunomedics
FinSMEs
-
September 13, 2020
1
USA
Tango Therapeutics Raises $50M in Equity Financing
FinSMEs
-
August 17, 2020
0
USA
Glympse Bio Raises $46.7M in Series B Financing
FinSMEs
-
July 24, 2020
0
USA
Gilead Sciences To Acquire 49.9 % Equity In Pionyr Immunotherapeutics, For $275M
FinSMEs
-
June 23, 2020
0
USA
Gilead To Buy Forty Seven, for $4.9 Billion
FinSMEs
-
March 21, 2020
0
USA
Tmunity Secures $75M in Series B Financing
FinSMEs
-
October 31, 2019
0
USA
Lyndra Therapeutics Raises $55M in Series B Financing
FinSMEs
-
January 29, 2019
0
USA
Glympse Bio Raises $22m Series A Financing
FinSMEs
-
October 9, 2018
0
USA
Precision BioSciences Raises $110M in Series B Funding
FinSMEs
-
June 26, 2018
0
USA
Tmunity Therapeutics Raises $100M in Series A Financing
FinSMEs
-
January 23, 2018
0
Denmark
Gilead Sciences Acquires EpiTherapeutics for $65M
FinSMEs
-
May 7, 2015
0
Sign-up now to the Daily Newsletter